Clinical Trial Update: Studies With 1,25-Dihydroxycholecalciferol [Phase 2]

View source ↗

Summary

Phase 2 studies of 1,25-dihydroxycholecalciferol for hypocalcemia and rickets were terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypocalcemia
• Rickets

Drugs mentioned

• Calcitriol (calcitriol)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hypocalcemia, Rickets | Phase 2 | Status: TERMINATED | Results posted: 2013-11-25